Close
Company Search
Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Update on Alteration Earth PLC Investment

4th May 2022 12:33

RNS Number : 3177K
Primorus Investments PLC
04 May 2022
 

Primorus Investments plc

 

("Primorus" or the "Company")

 

Update on Alteration Earth PLC Investment

 

Further to the RNS announcement dated 05 April 2022 in relation to the Company's (AIM: PRIM) investment into Alteration Earth PLC ("ALTE"), Primorus provides a brief update as set out below.

 

Primorus has signed a deed of amendment which extends the time for ALTE to complete its prospectus and obtain its listing on the Standard Segment of the Main Market of the London Stock Exchange.

 

The date has been extended from 4 May 2022 to 6 June 2022. 

 

The Company has been informed by ALTE that the delay was primarily because the FCA did not count any of the working days between 11 April (this being the date ALTE submitted its last prospectus proof for review) and 22 April as reading days (see: https://www.fca.org.uk/markets/listing-transactions-over-easter). This was done to enable the FCA to prioritise the most time sensitive transactions. 

 

Following this submission, and assuming no material issues are raised, ALTE is expecting to obtain its listing without any further amendments to the timeframe.

 

For further information please contact:

 

Primorus Investments plc

Matthew Beardmore, Chief Executive Officer

 

+44 (0) 20 8154 7907

 

Nominated Adviser

Cairn Financial Advisers LLP

Sandy Jamieson/James Caithie

 

+44 (0) 20 7213 0880

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
FURUSOARUUUVRAR

Related Shares:

Primorus Inv.
FTSE 100 Latest
Value8,759.00
Change-112.31